RC
Ramesh Cheruvu
About Ramesh Cheruvu
Data last updated:
Ramesh Cheruvu is a Whole-Time Director at Alphamed Formulations Private Limited (since 2018). The company operates in Pharma. Alphamed Formulations Private Limited reported revenue of ₹197 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 12 Jun 2018 | 2006 | ₹197 Cr (FY 2025) | Active |
Board colleagues of Ramesh Cheruvu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chris Mynhard Botha | 10312429 | Alphamed Formulations Private Limited | Director |
| Lorraine Angela Hill | 02337226 | Alphamed Formulations Private Limited | Director |
| Sudheer Reddy Gundu | Alphamed Formulations Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Cheruvu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Cheruvu
Ramesh Cheruvu currently holds 1 directorship: Alphamed Formulations Private Limited (Whole-Time Director, since 12 Jun 2018, revenue ₹197 Cr (FY 2025)).
Ramesh Cheruvu was first appointed on 12 Jun 2018 as Whole-Time Director at Alphamed Formulations Private Limited.
The current boards of Ramesh Cheruvu's companies include Chris Mynhard Botha (Alphamed Formulations Private Limited), Lorraine Angela Hill (Alphamed Formulations Private Limited), Sudheer Reddy Gundu (Alphamed Formulations Private Limited).